Cardiol Therapeutics annual asset turnover
2021
2022
2023
2024
2025
Cardiol Therapeutics Asset Turnover Growth & History (CRDL)
Cardiol Therapeutics's asset turnover was 0.00 for fiscal 2025.
View full Cardiol Therapeutics company overviewCardiol Therapeutics annual asset turnover history
| Fiscal year | Period ended | Asset turnover | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.00 | 0.00 | — |
| 2024 | 2024-12-31 | 0.00 | 0.00 | — |
| 2023 | 2023-12-31 | 0.00 | 0.00 | — |
| 2022 | 2022-12-31 | 0.00 | −0.00 | — |
| 2021 | 2021-12-31 | 0.00 | — | — |
Cardiol Therapeutics quarterly asset turnover
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Asset turnover | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.00 | — | — |
| Q1 2026 | 2026-03-31 | 0.00 | — | — |
| Q4 2025 | 2025-12-31 | 0.00 | — | — |
Cardiol Therapeutics asset turnover trends
Between the periods ended 2021-12-31 and 2025-12-31, Cardiol Therapeutics's asset turnover decreased from 0.00 to 0.00, a change of −0.00. The latest reported quarter, Q2 2026, shows 0.00.
About the metric
What asset turnover means
Asset turnover measures how much revenue a company generates for each unit of assets employed in the business. A higher ratio generally indicates more efficient asset use, although useful comparisons depend heavily on the industry.
Calculation and source
How asset turnover is calculated
TickerStat calculates annual asset turnover as reported revenue divided by average total assets. Quarterly values use trailing-12-month revenue and average assets over the corresponding one-year period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cardiol Therapeutics source filings ↗